120 related articles for article (PubMed ID: 37012)
1. Effects of equiblocking doses of nadolol and propranolol on left ventricular performance.
Le Winter MM; Curtis GP; Engler RL; Shabetai R; Verba J
Clin Pharmacol Ther; 1979 Aug; 26(2):162-6. PubMed ID: 37012
[TBL] [Abstract][Full Text] [Related]
2. Direct and beta adrenergic blocking actions of nadolol (SQ 11725) on electrophysiologic properties of isolated canine myocardium.
Gibson JK; Gelband H; Bassett AL
J Pharmacol Exp Ther; 1977 Sep; 202(3):702-10. PubMed ID: 19621
[TBL] [Abstract][Full Text] [Related]
3. Estimation of cardiodepressant potency of nadolol, alprenolol, propranolol and pindolol, beta-blocking agents, in heart-lung preparation and blood-perfused excised papillary muscle preparation of the dog.
Ono H; Kanazawa Y; O'Hara N; Hashimoto K
Jpn J Pharmacol; 1984 Dec; 36(4):507-17. PubMed ID: 6151997
[TBL] [Abstract][Full Text] [Related]
4. Class III action of beta-blocking agents.
Taggart P; Donaldson R; Abed J; Nashat F
Cardiovasc Res; 1984 Nov; 18(11):683-9. PubMed ID: 6149809
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the antifibrillatory activity of fluorinated derivatives of indenolol and nadolol in isolated rabbit and rat hearts: comparison with propranolol.
Almotrefi AA; Aboul-Enein HY; Premkumar LS
Arch Int Pharmacodyn Ther; 1989; 301():122-30. PubMed ID: 2576192
[TBL] [Abstract][Full Text] [Related]
6. Comparison of kinetic interactions of nadolol and propranolol with cimetidine.
Duchin KL; Stern MA; Willard DA; McKinstry DN
Am Heart J; 1984 Oct; 108(4 Pt 2):1084-6. PubMed ID: 6148867
[TBL] [Abstract][Full Text] [Related]
7. Effect of tolamolol versus propranolol on cardiovascular haemodynamics in patients with angina.
Aronow WS; March H; Vangrow JS; Cassidy J; Kern JC; Khemka M; Vawter M; Pagano J
Br Heart J; 1974 Nov; 36(11):1078-81. PubMed ID: 4155953
[No Abstract] [Full Text] [Related]
8. Comparative effects of propranolol and nadolol on renal blood flow in normal rats and rats with congestive heart failure.
Brenner BM; Duchin KL; Ichikawa I; Pfeffer J; Pfeffer M
Am Heart J; 1984 Oct; 108(4 Pt 2):1144-7. PubMed ID: 6148876
[TBL] [Abstract][Full Text] [Related]
9. Comparative potency of intravenous penbutolol and propranolol in man.
Sharma PL; Sapru RP
Int J Clin Pharmacol Biopharm; 1978 Feb; 16(2):83-5. PubMed ID: 24597
[TBL] [Abstract][Full Text] [Related]
10. Interactions of beta-adrenoceptor antagonists and thyroid hormones in the control of heart rate in the dog.
Allely MC; Ungar A
Br J Pharmacol; 1985 Oct; 86(2):393-8. PubMed ID: 2864972
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the effects of intravenous propranolol and nadolol on the renal response to hypertonic saline infusion.
Waller DG; Mihindukulasuriya J; Warren DJ
Br J Clin Pharmacol; 1985 Jan; 19(1):37-43. PubMed ID: 2858216
[TBL] [Abstract][Full Text] [Related]
12. Effects of oral equiblocking doses of a cardioselective and noncardioselective beta-adrenergic blocking agent on left ventricular function in the normal conscious dog.
LeWinter MM; Karliner JS; O'Rourke RA
Cardiovasc Res; 1978 Feb; 12(2):81-90. PubMed ID: 647714
[TBL] [Abstract][Full Text] [Related]
13. Cardiohemodynamic effects of nipradilol (K-351) in the dog: comparison with propranolol, nadolol and prazosin.
Kawada M; Satoh K; Taira N
Jpn J Pharmacol; 1986 Sep; 42(1):9-18. PubMed ID: 2879055
[TBL] [Abstract][Full Text] [Related]
14. Peripheral hemodynamic effects of short-term nadolol administration in essential hypertension.
Levenson J; Simon AC; Moyse D; Bouthier J; Safar ME
Am Heart J; 1984 Oct; 108(4 Pt 2):1177-82. PubMed ID: 6148882
[TBL] [Abstract][Full Text] [Related]
15. Systemic haemodynamic and beta-adrenoceptor antagonistic effects of bisoprolol in conscious pigs: a comparison with propranolol.
Duncker DJ; Saxena PR; Verdouw PD
Arch Int Pharmacodyn Ther; 1987 Nov; 290(1):54-63. PubMed ID: 2895611
[TBL] [Abstract][Full Text] [Related]
16. Antifibrillatory properties of the beta-adrenergic receptor antagonists, nadolol, sotalol, atenolol and propranolol, in the anesthetized dog.
Patterson E; Lucchesi BR
Pharmacology; 1984; 28(3):121-9. PubMed ID: 6144114
[TBL] [Abstract][Full Text] [Related]
17. Pharmacology of nadolol (SQ 11725), a beta-adrenergic antagonist lacking direct myocardial depression.
Lee RJ; Evans DB; Baky SH; Laffan RJ
Eur J Pharmacol; 1975; 33(2):371-82. PubMed ID: 241655
[TBL] [Abstract][Full Text] [Related]
18. Effects of prolonged treatment with adrenergic beta-receptor antagonists on blood pressure, cardiovascular design and reactivity in spontaneously hypertensive rats (SHR).
Weiss L; Lundgren Y; Folkow B
Acta Physiol Scand; 1974 Aug; 91(4):447-57. PubMed ID: 4154700
[No Abstract] [Full Text] [Related]
19. Effects of tertatolol, a beta-adrenoceptor antagonist with agonist affinity at 5-HT1A receptors, in an animal model of migraine: comparison with propranolol and pindolol.
Saxena PR; Heiligers JP; Villalón CM; Ferrari MD
Eur J Pharmacol; 1992 Sep; 220(1):79-86. PubMed ID: 1358648
[TBL] [Abstract][Full Text] [Related]
20. Pharmacologic antagonism of beta-adrenergic blockade in dogs. I. Hemodynamic effects of isoproterenol, dopamine, and epinephrine in acute propranolol administration.
Avery GJ; Spotnitz HM; Rose EA; Malm JR; Hoffman BF
J Thorac Cardiovasc Surg; 1979 Feb; 77(2):267-76. PubMed ID: 33298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
